TY - JOUR
T1 - Low Hospice Utilization in New York State
T2 - Comparisons Using National Data
AU - Dhingra, Lara
AU - Braveman, Carla
AU - Kassner, Cordt
AU - Schechter, Clyde
AU - DiFiglia, Stephanie
AU - Portenoy, Russell
N1 - Funding Information:
We wish to thank Jack Chen for his assistance with study implementation, the hospice agencies and staff for coordinating and hosting the sessions, and the individuals who participated in the sessions. We gratefully acknowledge the MJHS Foundation for supporting this work.
Publisher Copyright:
© 2021 American Academy of Hospice and Palliative Medicine
PY - 2022/4
Y1 - 2022/4
N2 - Context: Hospice utilization in New York State (NYS) is low compared to the rest of the U.S. Objectives: The first part of a mixed-methods study elicited information from New York State stakeholders and identified 54 hospice-related barriers in nine categories, some specific to NYS. This second part used national data to examine the differences between NYS and the rest of the country by evaluating the variables associated with low NYS hospice utilization. Methods: Ten Medicare or publicly available datasets provided data from the year prior to death for all traditional Medicare-insured patients dying in 2018. Multivariate analyses identified variables independently associated with differences in hospice enrollment or length of stay between NYS and the rest of the country. Results: The NYS population was relatively older, included more women and minorities, had higher socioeconomic status (SES), and saw more physicians during the last two years of life. NYS had more physicians, more skilled nursing facility (SNF) beds, and fewer for-profit hospitals, SNFs, home care agencies, and hospice agencies. In multivariate analyses, lower NYS hospice utilization was associated with higher SES; more physicians seen during the last two years of life; more SNF beds and fewer for-profit SNF facilities; and fewer hospice agencies. Conclusion: NYS's low hospice utilization is independently associated with diverse factors, including those related to the health care system. Combined with information from stakeholders, these findings may help target, and inform initiatives to improve hospice utilization.
AB - Context: Hospice utilization in New York State (NYS) is low compared to the rest of the U.S. Objectives: The first part of a mixed-methods study elicited information from New York State stakeholders and identified 54 hospice-related barriers in nine categories, some specific to NYS. This second part used national data to examine the differences between NYS and the rest of the country by evaluating the variables associated with low NYS hospice utilization. Methods: Ten Medicare or publicly available datasets provided data from the year prior to death for all traditional Medicare-insured patients dying in 2018. Multivariate analyses identified variables independently associated with differences in hospice enrollment or length of stay between NYS and the rest of the country. Results: The NYS population was relatively older, included more women and minorities, had higher socioeconomic status (SES), and saw more physicians during the last two years of life. NYS had more physicians, more skilled nursing facility (SNF) beds, and fewer for-profit hospitals, SNFs, home care agencies, and hospice agencies. In multivariate analyses, lower NYS hospice utilization was associated with higher SES; more physicians seen during the last two years of life; more SNF beds and fewer for-profit SNF facilities; and fewer hospice agencies. Conclusion: NYS's low hospice utilization is independently associated with diverse factors, including those related to the health care system. Combined with information from stakeholders, these findings may help target, and inform initiatives to improve hospice utilization.
KW - Hospice
KW - New York State
KW - advanced illness
KW - end-of-life care
KW - palliative care
UR - http://www.scopus.com/inward/record.url?scp=85122921317&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85122921317&partnerID=8YFLogxK
U2 - 10.1016/j.jpainsymman.2021.12.013
DO - 10.1016/j.jpainsymman.2021.12.013
M3 - Article
C2 - 34954063
AN - SCOPUS:85122921317
SN - 0885-3924
VL - 63
SP - 522
EP - 529
JO - Journal of Pain and Symptom Management
JF - Journal of Pain and Symptom Management
IS - 4
ER -